Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy - PubMed (original) (raw)

. 2022 Feb;24(2):388-392.

doi: 10.1007/s12094-021-02693-8. Epub 2021 Aug 21.

Affiliations

Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy

L Murillo-Sanjuán et al. Clin Transl Oncol. 2022 Feb.

Abstract

Introduction: Hematopoietic stem cell transplantation (HSCT) is a curative option for patients with Fanconi anemia (FA) and hematological manifestations but it does not prevent solid tumors, especially squamous cell carcinomas (SCC).

Methods: Retrospective study in 22 FA patients who had received HSCT and had been followed up beyond 2 years after HSCT.

Results: The median follow-up was 15 years. Six patients developed head-and-neck SCC after transplantation. The cumulative incidence of SCC at 15 and 30 years from the HSCT was 14.2% and 71.2%, respectively. One patient was diagnosed in stage IV and the rest, who were being followed up in cancer screening programs, in stage I. Treatment of SCC consisted of surgery in all patients; radiotherapy and chemotherapy were used in two patients and were poorly tolerated.

Conclusion: FA patients have high risk of head-and-neck SCC. Multi-disciplinary programs for early cancer detection are of special relevance in these patients.

Keywords: Fanconi anemia; Head and neck squamous cell carcinoma; Hematopoietic stem cell transplantation; Multi-disciplinary approach.

© 2021. Federación de Sociedades Españolas de Oncología (FESEO).

PubMed Disclaimer

References

    1. Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res Mol Mech Mutagen. 2009;668:4–10. https://doi.org/10.1016/j.mrfmmm.2009.01.013 . -DOI
    1. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822–6. https://doi.org/10.1182/blood-2002-05-1498 . -DOI -PubMed
    1. Rosenberg PS, Socié G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67–73. https://doi.org/10.1182/blood-2004-04-1652 . -DOI -PubMed
    1. Masserot C, Peffault-de-Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, et al. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer. 2008;113:3315–22. https://doi.org/10.1002/cncr.23954 . -DOI -PubMed
    1. Velleuer E, Dietrich R, Pomjanski N, Santana-Almeida-Araujo IK, Silva-de-Araujo BE, Sroka I, et al. Diagnostic accuracy of brush biopsy–based cytology for the early detection of oral cancer and precursors in Fanconi anemia. Cancer Cytopathol. 2020;128:403–13. https://doi.org/10.1002/cncy.22249 . -DOI -PubMed

MeSH terms

LinkOut - more resources